RVU
RYVU THERAPEUTICS GPW LISTED

Shareholders

as of June 30, 2026 · source: notifications under Art. 69 of the Offering Act · 5 entities above 5% of votes

FREE FLOAT
52.64%
12,170,036 shares
LARGEST STAKE
17.22%
Paweł Przewięźlikowski (poprzez Benevora Polska Fundacja Rodzinna)
TOP 3 CONCENTRATION
35.43%
3 entities above 5% of votes
LATEST CHANGE
June 25, 2026
ESPI (wykaz z WZ)

Ownership structure

stakes per latest notifications · shares outstanding: 23,120,148 (report, Jun 30, 2026)
SHAREHOLDERS ≥5% OF VOTES 47.36% FREE FLOAT 52.64%
Paweł Przewięźlikowski (poprzez Benevora Polska Fundacja Rodzinna) 17.22%
3,982,160 shares NOTIFICATION: Jun 30, 2026
Allianz Polska OFE Polska 9.92%
2,292,540 shares NOTIFICATION: Jun 30, 2026
BioNTech SE Niemcy 8.29%
1,917,437 shares NOTIFICATION: Jun 30, 2026
Nationale Nederlanden OFE Polska 5.99%
1,385,262 shares NOTIFICATION: Jun 30, 2026
Tadeusz Wesołowski (wraz z Fundacją Rodziną Rodziny Wesołowskich Fundacja Rodzinna w Krakowie) 5.94%
1,372,713 shares NOTIFICATION: Jun 30, 2026
FREE FLOAT — BELOW 5% OF VOTES
Otwarty Fundusz Emerytalny PZU Złota Jesień 5.7%
1,317,374 shares NOTIFICATION: Jun 25, 2026
Zarząd+RN pozostali 2.03%
468,431 shares NOTIFICATION: Jun 30, 2026
Other 44.91%
10,384,231 shares composition undisclosed

Capital and votes

Number of shares
23,120,148
ISIN
PLSELVT00013
Sector
Biotechnologia
Market
GPW
Country
PL
Listing date
July 01, 2011

Where this data comes from

The structure is built from notifications shareholders file after crossing 5%, 10%, 15%, 20%, 25%, 33%, 50%, 75% and 90% of votes.

Below 5% there is no disclosure obligation, so the remaining capital is shown collectively as free float — its composition is not publicly known.

Stakes are not updated in real time. The date next to each entity is its last notification date, not today's date.

The share count behind every percentage comes from the newest (by as-of date) periodic report or art. 69 notification — not from the company's GPW/NewConnect profile.